News

Promising autism drugs progress through pipeline

Publish date: May 30, 2013

 

EXPERT ANALYSIS FROM THE NCDEU MEETING

Dr. Sikich and Dr. Urbano reported having no relevant financial interests. Dr. McCracken is a consultant to Roche and Seaside.

Pages

Recommended Reading

Childhood migraine tied to history of infantile colic
MDedge Neurology
Manage most SEGAs with rapamycin analogs, not surgery
MDedge Neurology
Autism, autism spectrum disorder risk increased with prenatal valproate exposure
MDedge Neurology
Five ways the DSM-5 could change your practice
MDedge Neurology
No correlation found between autism and Lyme disease
MDedge Neurology
No or mild developmental disability in 73% of extremely preterm
MDedge Neurology
Congress creates caucus for Tourette syndrome
MDedge Neurology
Study supports laws requiring cyclists to wear helmets
MDedge Neurology
Hypertension hurts memory, attention in children
MDedge Neurology
DSM-5 criteria 'at odds' with early autism diagnosis
MDedge Neurology